A detailed history of Sage Financial Management Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Sage Financial Management Group, Inc. holds 1,393 shares of ABBV stock, worth $231,962. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,393
Holding current value
$231,962
% of portfolio
0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $222,629 - $253,665
1,393 New
1,393 $254,000
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $1.02 Million - $1.13 Million
-10,000 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $804,900 - $1.09 Million
10,000 New
10,000 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sage Financial Management Group, Inc. Portfolio

Follow Sage Financial Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Financial Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sage Financial Management Group, Inc. with notifications on news.